GO:0033565 ESCRT-0 complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033565 (ESCRT-0 complex) is a cellular_component term describing a protein complex required for recycling of Golgi proteins, formation of lumenal membranes and sorting of ubiquitinated proteins into those membranes.
• In mammals the complex is composed of Hrs (HGS) and STAM proteins; in yeast the orthologous complex is Vps27p-Hse1p.
• ESCRT-0 assembles as a heterotetrameric complex on membranes and can bind multiple ubiquitinylated cargoes simultaneously.
• ESCRT-0 complex formation on the vacuolar membrane is regulated by TORC1, PP2A and Cdc14 in yeast, linking it to microautophagy induction [2,3,4].
• ESCRT-0 components such as HRS regulate small extracellular vesicle PD-L1 secretion and are associated with anti-PD-1 treatment efficacy.
• The ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling.
Description
The ESCRT-0 complex (GO:0033565) is a membrane-associated protein complex that functions at the earliest step of the endosomal sorting complexes required for transport (ESCRT) pathway. According to the Gene Ontology, it is required for the recycling of Golgi proteins, the formation of lumenal membranes and the sorting of ubiquitinated proteins into those membranes. In mammals the complex is built from Hrs (also known as HGS) and STAM proteins, while in yeast the orthologous complex comprises Vps27p and Hse1p. Because it recognizes ubiquitinated cargo and initiates their concentration on endosomal membranes, ESCRT-0 is a central node for receptor downregulation, extracellular vesicle biogenesis and cellular signaling [5,6]. Researchers study GO:0033565 to understand how cells route ubiquitinated membrane proteins, how ESCRT-0 assembly is controlled by nutrient-sensing kinases and phosphatases, and how its dysfunction contributes to cancer and other diseases [2,3,4,6,7]. The complex has also become a target for CRISPR-based functional genomics, because loss- or gain-of-function models of HGS, STAM and their partners can reveal causal roles in trafficking, autophagy and tumor immunity [6,7].
ESCRT-0 complex At A Glance
| GO ID | GO:0033565 |
|---|---|
| GO term | ESCRT-0 complex |
| Ontology | cellular_component |
| Synonym | Hrs/STAM complex; Vps27p-Hse1p complex |
| Major function | Recycling of Golgi proteins, formation of lumenal membranes and sorting of ubiquitinated proteins into those membranes |
| Yeast components | Vps1p and Hse1p |
| Mammalian components | Hrs and STAM proteins |
| Assembly state | Heterotetrameric complex on membranes |
| Cargo property | Binds multiple ubiquitinylated cargoes simultaneously |
What Is GO:0033565?
In plain terms, the ESCRT-0 complex is the first sorting station of the ESCRT machinery. It is a protein complex that sits on endosomal membranes and captures ubiquitinated cargo proteins, helping to recycle Golgi proteins, build lumenal membranes and sort ubiquitinated proteins into those membranes. The complex includes Vps1p and Hse1p in yeast and the Hrs and STAM proteins in mammals. It is annotated as a cellular_component because it describes a physical assembly of proteins rather than an enzymatic activity or a biological process.
Why Is ESCRT-0 complex Important in Cell Biology?
The ESCRT-0 complex is important because it sets the selectivity of the entire ESCRT pathway: by binding ubiquitinated cargoes and assembling as a heterotetramer on membranes, it determines which proteins are sorted into lumenal membranes and which are recycled. This sorting decision influences receptor downregulation, extracellular vesicle cargo loading and signaling outcomes, including EGFR signaling and PD-L1 secretion [6,7]. In yeast, ESCRT-0 complex formation on the vacuolar membrane is a regulated step in microautophagy induction, controlled by TORC1, PP2A and Cdc14 [2,3,4]. Consequently, GO:0033565 is relevant to cancer biology, autophagy, membrane trafficking and immunology, and it provides a tractable entry point for CRISPR screens and mechanistic cell models [6,7].
• Defines the first sorting step of the ESCRT pathway by capturing ubiquitinated cargoes.
• Controls recycling of Golgi proteins and formation of lumenal membranes.
• Assembles as a heterotetramer that can bind multiple ubiquitinylated cargoes at once.
• Regulates microautophagy induction at the vacuolar membrane in yeast [2,3,4].
• Modulates Rbf-mutant cell survival through Rhomboid endosomal trafficking and EGFR signaling.
• Regulates small extracellular vesicle PD-L1 secretion and anti-PD-1 treatment efficacy.
• Is linked to exosome biogenesis and cancer metastasis through GPR143-dependent ESCRT function.
• Provides a target for CRISPR knockout, knock-in and overexpression models in trafficking research [6,7].
• Connects nutrient sensing (TORC1) to membrane remodeling and autophagy [2,3,4].
• Offers biomarkers and therapeutic hypotheses in immuno-oncology and metastasis [1,6].
What Happens During ESCRT-0 complex?
Cargo recognition and ubiquitin binding
In simple terms: ESCRT-0 grabs proteins that have been tagged with ubiquitin.
The ESCRT-0 complex recognizes ubiquitinated cargo proteins and concentrates them on endosomal membranes, which is the sorting event that defines the complex's role in the ESCRT pathway. In mammals, Hrs and STAM form the core of this recognition module, while in yeast Vps27p and Hse1p perform the equivalent function. This step is required for the recycling of Golgi proteins and for the formation of lumenal membranes into which ubiquitinated proteins are sorted.
Heterotetrameric assembly on membranes
In simple terms: ESCRT-0 builds a four-part machine on the membrane surface.
ESCRT-0 assembles as a heterotetrameric complex on membranes and can bind multiple ubiquitinylated cargoes simultaneously. This multivalent architecture allows the complex to cluster cargo and initiate the membrane remodeling events that lead to lumenal membrane formation. The assembly state is therefore a key determinant of sorting efficiency and downstream ESCRT function.
Regulation by TORC1 and phosphatases
In simple terms: Nutrient signals and phosphatases switch ESCRT-0 assembly on and off.
In yeast, TORC1 regulates ESCRT-0 complex formation on the vacuolar membrane and microautophagy induction. After TORC1 inactivation, PP2A promotes ESCRT-0 complex formation on vacuolar membranes and microautophagy induction, whereas Cdc14 phosphatase downmodulates ESCRT-0 complex formation on vacuolar membranes and microautophagy. These findings establish that ESCRT-0 assembly is a dynamically regulated step rather than a constitutive event [2,3,4].
Downstream membrane remodeling and microautophagy
In simple terms: Once assembled, ESCRT-0 helps reshape membranes and trigger microautophagy.
ESCRT-0 complex formation on the vacuolar membrane is coupled to microautophagy induction in yeast, linking cargo sorting to autophagic membrane remodeling [2,3,4]. In mammalian cells, ESCRT-dependent processes contribute to exosome biogenesis and small extracellular vesicle cargo secretion, including PD-L1 [1,6]. The complex therefore sits at the interface of endosomal sorting, autophagy and extracellular vesicle biology [1,2,6].
Crosstalk with RAB conversion and signaling
In simple terms: ESCRT-0 works together with RAB switches and signaling pathways.
ESCRT function is coordinated with RAB GTPase conversion, which organizes membrane identity transitions during sorting. In Drosophila, the ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling. These observations show that ESCRT-0 is embedded in broader trafficking and signaling networks rather than acting in isolation [7,8].
Key Genes Involved in GO:0033565 ESCRT-0 complex
The following genes and proteins are the principal components and regulators of the ESCRT-0 complex (GO:0033565) and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HGS (Hrs) | Mammalian ESCRT-0 core component; ubiquitinated cargo recognition | Knockout and tagged knock-in models for sorting and EV studies [5,6] |
| STAM | Mammalian ESCRT-0 core component; Hrs/STAM complex partner | Knockout and point-mutation models for cargo binding |
| VPS27 | Yeast ESCRT-0 core component (Vps27p) | Yeast genetics and microautophagy assays [2,3,4] |
| HSE1 | Yeast ESCRT-0 core component (Hse1p) | Yeast genetics and vacuolar membrane assembly studies [2,3,4] |
| TORC1 | Nutrient-sensing kinase regulating ESCRT-0 formation | Upstream regulator in microautophagy models |
| PP2A | Phosphatase promoting ESCRT-0 complex formation | Regulation of vacuolar membrane assembly |
| CDC14 | Phosphatase downmodulating ESCRT-0 complex formation | Regulation of microautophagy after TORC1 inactivation |
| GPR143 | Controls ESCRT-dependent exosome biogenesis | Cancer metastasis and exosome models |
| RAB GTPases | Membrane identity switches coordinating ESCRT function | Trafficking and conversion studies |
| RHOMBOID | Endosomal cargo regulated by ESCRT-0 in Drosophila | EGFR signaling and cell survival models |
| EGFR | Signaling receptor influenced by ESCRT-0-dependent trafficking | Rbf-mutant survival and signaling assays |
| PD-L1 (CD274) | Small extracellular vesicle cargo regulated by HRS | Anti-PD-1 efficacy and immuno-oncology models |
| RBF | Drosophila retinoblastoma family protein | Cell survival and ESCRT-0 genetic interaction studies |
| VPS1 | Yeast component listed in the GO definition | Yeast ESCRT-0 complex annotation |
| HRS/STAM complex | Synonym for the mammalian ESCRT-0 complex | Nomenclature and annotation studies |
| Vps27p-Hse1p complex | Synonym for the yeast ESCRT-0 complex | Nomenclature and annotation studies |
How Is ESCRT-0 complex Regulated?
ESCRT-0 complex formation is regulated by nutrient-sensing and phosphatase pathways. In yeast, TORC1 regulates ESCRT-0 complex formation on the vacuolar membrane and microautophagy induction. After TORC1 inactivation, PP2A promotes ESCRT-0 complex formation on vacuolar membranes and microautophagy induction, while Cdc14 phosphatase downmodulates ESCRT-0 complex formation on vacuolar membranes and microautophagy. These studies show that the assembly state of ESCRT-0 is dynamically controlled by opposing kinase and phosphatase activities [2,3,4]. In addition, ESCRT function is coordinated with RAB GTPase conversion, which organizes membrane identity transitions during sorting.
ESCRT-0 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR143 | Cancer metastasis and exosome biogenesis | Knockout cancer cell lines with exosome isolation |
| HGS (Hrs) | Small extracellular vesicle PD-L1 secretion and anti-PD-1 efficacy | Knockout and overexpression models in tumor cells |
| STAM | Endosomal sorting and cargo trafficking | Point-mutation and knockout cell models |
| RBF | Cell survival and EGFR signaling in Drosophila | Genetic interaction and knock-in models |
| VPS27/HSE1 | Microautophagy and vacuolar membrane assembly | Yeast knockout and phosphatase-regulator models [2,3,4] |
Cancer metastasis and exosome biogenesis
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, linking ESCRT pathway activity to metastatic behavior. Because ESCRT-0 initiates cargo sorting into lumenal membranes, its function can influence which proteins are packaged into exosomes and released from tumor cells [1,5].
Immuno-oncology and PD-L1 secretion
HRS regulates small extracellular vesicle PD-L1 secretion and is associated with anti-PD-1 treatment efficacy. This connects the ESCRT-0 complex to immune checkpoint biology and suggests that ESCRT-0 components may modulate responses to immunotherapy.
Cell survival and EGFR signaling
The ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling. This genetic interaction indicates that ESCRT-0 dysfunction can alter signaling output and cell survival decisions in proliferative tissues.
Autophagy and nutrient stress
ESCRT-0 complex formation on the vacuolar membrane is required for microautophagy induction after TORC1 inactivation, and this step is tuned by PP2A and Cdc14 [2,3,4]. Defects in this regulation could impair autophagic membrane remodeling under nutrient stress [2,3,4].
From ESCRT-0 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HGS alter PD-L1 secretion in extracellular vesicles? | HGS knockout tumor cell line with EV isolation |
| Does STAM ubiquitin-binding domain mutation affect cargo sorting? | STAM point-mutation knock-in cell line |
| How does TORC1 inactivation change ESCRT-0 assembly? | Yeast VPS27/HSE1 tagged knock-in with vacuolar imaging |
| Does PP2A or Cdc14 modulation change microautophagy? | Yeast phosphatase knockout or overexpression models [3,4] |
| Does GPR143-dependent ESCRT activity promote metastasis? | GPR143 knockout cancer cells in metastasis assays |
| Does ESCRT-0 modulate EGFR signaling in Rbf-mutant cells? | Drosophila genetic models with ESCRT-0 knockdown |
How to Study the ESCRT-0 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Membrane localization and assembly of ESCRT-0 | Vacuolar membrane complex formation [2,3,4] |
| Co-immunoprecipitation | Protein-protein interactions and complex composition | Heterotetrameric assembly validation |
| Native gel electrophoresis | Complex size and stoichiometry | ESCRT-0 assembly state |
| Extracellular vesicle isolation | Cargo content of small EVs | PD-L1 secretion studies |
| CRISPR knockout screening | Causal gene requirements in sorting pathways | HGS/STAM functional genomics [6,7] |
| Genetic interaction assays | Modifier effects on signaling and survival | Drosophila Rbf-mutant models |
| Exosome biogenesis assays | ESCRT-dependent vesicle production | Cancer metastasis models |
| RAB conversion profiling | Membrane identity transitions | Trafficking coordination studies |
Imaging ESCRT-0 assembly on membranes
Fluorescence imaging of tagged ESCRT-0 components allows researchers to visualize complex formation on vacuolar or endosomal membranes and to quantify assembly changes after TORC1 inactivation or phosphatase manipulation [2,3,4]. Tagged knock-in models are particularly useful because they preserve endogenous expression levels.
Biochemical analysis of complex composition
Biochemical approaches such as co-immunoprecipitation and native gel analysis can determine whether ESCRT-0 assembles as a heterotetramer and whether it binds multiple ubiquitinylated cargoes simultaneously. These assays are essential for validating structural and stoichiometric claims about the complex.
Extracellular vesicle and cargo profiling
Isolation and profiling of small extracellular vesicles can measure how ESCRT-0 components such as HRS influence cargo secretion, including PD-L1. Combining EV profiling with CRISPR knockout of HGS or STAM provides causal evidence for sorting specificity.
Genetic interaction and signaling assays
Genetic interaction studies in model organisms, such as Drosophila Rbf-mutant cells, can test whether ESCRT-0 modulates Rhomboid trafficking and EGFR signaling. These assays link molecular sorting defects to cell survival and signaling outcomes.
How CRISPR Can Be Used to Study GO:0033565 ESCRT-0 complex
Knockout
CRISPR knockout of HGS, STAM or their yeast orthologs VPS27 and HSE1 can abolish ESCRT-0 complex function and reveal its requirement for cargo sorting, microautophagy and extracellular vesicle secretion [2,5,6]. Knockout models are the most direct way to test whether a candidate gene is causally involved in ESCRT-0-dependent phenotypes.
Point Mutation
Point mutations in ubiquitin-binding or protein-interaction domains of STAM or HGS can dissect which residues are required for binding multiple ubiquitinylated cargoes simultaneously. Such models preserve the rest of the complex and isolate specific molecular functions.
Knock-in
Tagged knock-in of VPS27 or HSE1 in yeast allows endogenous-level visualization of ESCRT-0 complex formation on vacuolar membranes and its regulation by TORC1, PP2A and Cdc14 [2,3,4]. Knock-in reporters avoid overexpression artifacts and support quantitative imaging.
Overexpression
Overexpression of ESCRT-0 components or regulators such as GPR143 can drive exosome biogenesis and metastasis-related phenotypes, providing gain-of-function evidence complementary to knockout studies. Overexpression models are useful when the research question concerns pathway activation rather than loss of function.
How EDITGENE Supports ESCRT-0 complex Research
Researchers studying ESCRT-0 complex-related genes often need to determine whether a candidate gene is causally involved in cargo sorting, microautophagy or extracellular vesicle secretion, or whether it is merely correlated with the phenotype. EDITGENE provides publication-ready CRISPR cell models and screening services that let you move from hypothesis to causal evidence for GO:0033565 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for ESCRT-0 complex research.
Frequently Asked Questions About ESCRT-0 complex
What is the ESCRT-0 complex?
The ESCRT-0 complex (GO:0033565) is a protein complex required for the recycling of Golgi proteins, formation of lumenal membranes and sorting of ubiquitinated proteins into those membranes; it includes Vps1p and Hse1p in yeast and Hrs and STAM in mammals.
What genes are involved in the ESCRT-0 complex?
Key genes include HGS (Hrs) and STAM in mammals, and VPS27 and HSE1 in yeast, with regulators such as TORC1, PP2A and Cdc14 controlling assembly in yeast [2,3,4,5].
Where does the ESCRT-0 complex act in the cell?
It acts on membranes, including endosomal and vacuolar membranes, where it assembles as a heterotetramer and binds ubiquitinylated cargoes [2,5].
How is ESCRT-0 complex formation regulated?
In yeast, TORC1 regulates ESCRT-0 complex formation on the vacuolar membrane, PP2A promotes it after TORC1 inactivation, and Cdc14 downmodulates it [2,3,4].
What is the role of ESCRT-0 in microautophagy?
ESCRT-0 complex formation on the vacuolar membrane is coupled to microautophagy induction after TORC1 inactivation [2,3,4].
Is ESCRT-0 involved in cancer?
Yes, GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis, and HRS regulates small extracellular vesicle PD-L1 secretion associated with anti-PD-1 treatment efficacy [1,6].
How does ESCRT-0 affect EGFR signaling?
The ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling.
What is the difference between ESCRT-0 and other ESCRT complexes?
ESCRT-0 is the initial sorting complex that recognizes ubiquitinated cargo and assembles as a heterotetramer on membranes, as defined for GO:0033565.
How can CRISPR be used to study the ESCRT-0 complex?
CRISPR knockout, point mutation, knock-in and overexpression models can test causal roles of HGS, STAM, VPS27 and HSE1 in sorting, microautophagy and extracellular vesicle secretion [2,5,6].
What methods are used to study ESCRT-0 complex assembly?
Fluorescence imaging of tagged components, co-immunoprecipitation, native gel analysis and extracellular vesicle profiling are commonly used [2,5,6].
Conclusion
The ESCRT-0 complex (GO:0033565) is the entry point of the ESCRT sorting pathway, responsible for recognizing ubiquitinated cargo, assembling as a heterotetramer on membranes and directing proteins into lumenal membranes. Its formation is dynamically regulated by TORC1, PP2A and Cdc14 in yeast, linking it to microautophagy [2,3,4]. In mammals, ESCRT-0 components influence extracellular vesicle cargo secretion, PD-L1 biology and cancer metastasis, making the complex a compelling target for mechanistic and translational research [1,6]. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide the causal toolkit needed to dissect these functions and to identify new therapeutic opportunities [6,7].
References
- 1. Lee YJ et al.. 2023. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.. Dev Cell 58(4):320-334.e8 PMID: 36800996
- 2. Morshed S et al.. 2020. TORC1 regulates ESCRT-0 complex formation on the vacuolar membrane and microautophagy induction in yeast.. Biochem Biophys Res Commun 522(1):88-94 PMID: 31740006
- 3. Sharmin T et al.. 2021. Cdc14 phosphatase downmodulates ESCRT-0 complex formation on vacuolar membranes and microautophagy after TORC1 inactivation.. Biochem Biophys Res Commun 561:158-164 PMID: 34023781
- 4. Sharmin T et al.. 2020. PP2A promotes ESCRT-0 complex formation on vacuolar membranes and microautophagy induction after TORC1 inactivation.. Biochem Biophys Res Commun 524(3):614-620 PMID: 32029270
- 5. Mayers JR et al.. 2011. ESCRT-0 assembles as a heterotetrameric complex on membranes and binds multiple ubiquitinylated cargoes simultaneously.. J Biol Chem 286(11):9636-45 PMID: 21193406
- 6. Xiao BL et al.. 2023. HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy.. Cancer Immunol Res 11(2):228-240 PMID: 36484721
- 7. Sheng Z et al.. 2016. ESCRT-0 complex modulates Rbf-mutant cell survival by regulating Rhomboid endosomal trafficking and EGFR signaling.. J Cell Sci 129(10):2075-84 PMID: 27056762
- 8. Solinger JA et al.. 2025. ESCRTing the RABs through conversion.. Biochem Soc Trans 53(2):431-445 PMID: 40605338
